Bio Essence Corp (BIOE) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US09090C1053
Price
0.44 USD
Market cap
23.68 m USD
P/E (2025)
22.00
P/S (2025)
12.48
Dividend yield
0.00 %
Net margin
47.23 %
Return on equity (ROE)
-43.23 %
Return on assets (ROA)
212.13 %
Bio Essence Corp financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 323,940.00 USD | 1.90 m USD |
| Gross profit | 217,077.00 USD | 1.43 m USD |
| Operating income | -459,438.00 USD | 900,011.00 USD |
| EBIT | -1.31 m USD | 899,183.00 USD |
| Net income | -1.31 m USD | 896,197.00 USD |
| Diluted EPS – continuing operations | -0.03 USD | 0.02 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Bio Essence Corp
Bio Essence Corporation engages in manufacturing and distributing health supplement products. It also offers original equipment manufacturing, and private label services for dietary supplements, vitamins, and herbal nutrition products. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.
More stocks
- Xos, Inc. (XOS)
- Mono Next Public Company Limited (MONO.BK)
- ATLANTIC AMERICAN CORP (AAME)
- Tonix Pharmaceuticals Holding Corp. (TNXP)
- CervoMed Inc. (CRVO)
- Lite Strategy, Inc. (LITS)
- Scientist Home Future Health Ltd (SHFH)
- ConnectM Technology Solutions, Inc. (CNTM)
- OLD MARKET CAPITAL Corp (OMCC)
- HeartBeam, Inc. (BEAT)
- PIONEER POWER SOLUTIONS, INC. (PPSI)
- TABLE TRAC INC (TBTC)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.